H.C. Wainwright raised the firm’s price target on Greenwich LifeSciences (GLSI) to $39 from $38 and keeps a Buy rating on the shares. The ...

The amount of new funding was not disclosed. Grenova said the round was led by Greenwich, Connecticut’s Peloton Equity — ...

Deep Track Capital, LP, (together with its affiliates, "Deep Track" or "we"), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) ("Dynavax", "DVAX" or the "Company"), ...

Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously ...

GREENWICH — Whether it was at home with his family or while teaching at Greenwich High School, Joe Baske made the people around him feel like they mattered. "He prioritized relationships and ...

GREENWICH — Even after losing a primary donor, the Greenwich Department of Human Services is working hard to continue to make summer camp accessible for kids from low-income families through its ...

IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the ...

Plans to prohibit ice cream vans from trading on a street next to Greenwich Park have prompted a local councillor to state that the local authority is not "anti-ice cream". Greenwich Council's ...

In a report released today, James Condulis from Stifel Nicolaus maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price ...